Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Current Developments in Nutrition
|
May 22, 2019
Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands
Adriana V Gaitán, JodiAnne T Wood, Noel W Solomons, et al.
Nature Communications
|
May 10, 2023
Structural basis for activation of CB1 by an endocannabinoid analog
Kaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, et al.
Psychopharmacology
|
November 24, 2023
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice
Jimit Girish Raghav, Hritik Kumar, Lipin Ji, et al.
Journal of Medicinal Chemistry
|
September 15, 2025
Exceptionally Potent Chiral Anandamide Analogs
Markos-Orestis Georgiadis, Elena Ferreras, Lipin Ji, et al.
Journal of Medicinal Chemistry
|
June 26, 2025
Novel Tetraolefinic Chain Phenyl Substituted Endocannabinoid Probes
Markos-Orestis Georgiadis, Lipin Ji, Fei Tong, et al.
European Journal of Medicinal Chemistry
|
January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists
Ioannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Journal of Medicinal Chemistry
|
September 11, 2018
( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes
Yingpeng Liu, Lipin Ji, Marsha Eno, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Current Developments in Nutrition
|
May 22, 2019
Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands
Adriana V Gaitán, JodiAnne T Wood, Noel W Solomons, et al.
Nature Communications
|
May 10, 2023
Structural basis for activation of CB1 by an endocannabinoid analog
Kaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, et al.
Psychopharmacology
|
November 24, 2023
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice
Jimit Girish Raghav, Hritik Kumar, Lipin Ji, et al.
Journal of Medicinal Chemistry
|
September 15, 2025
Exceptionally Potent Chiral Anandamide Analogs
Markos-Orestis Georgiadis, Elena Ferreras, Lipin Ji, et al.
Journal of Medicinal Chemistry
|
June 26, 2025
Novel Tetraolefinic Chain Phenyl Substituted Endocannabinoid Probes
Markos-Orestis Georgiadis, Lipin Ji, Fei Tong, et al.
European Journal of Medicinal Chemistry
|
January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists
Ioannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
Journal of Medicinal Chemistry
|
September 11, 2018
( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes
Yingpeng Liu, Lipin Ji, Marsha Eno, et al.
Page
of 2